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The Cdc48 chaperone, also called p97 or VCP in higher eukaryotes, is
a phylogenetically highly conserved member of the AAA-ATPases
family involved in many cellular functions including protein degrada-
tion, endoplasmic reticulum-associated degradation (ERAD), cell cycle
progression, membrane fusion or DNA repair. It consists of a homo-
hexamer, each monomer presenting two AAA cassettes that couple
ATP-hydrolysis to conformational changes of the entire complex [1].
Ability to primarily interact with ubiquitined targets represents the
second essential property of Cdc48/p97 [2]. Together, these character-
istics are believed to support a “segregase“ function for Cdc48/p97 that
uses energy provided by ATP hydrolysis to segregate ubiquitinated
substrates from protein complexes, cell membranes and chromatin and
to release them for either proteasomal degradation or recycling [3–7].
The diversity of cellular functions controlled by Cdc48/p97 is mediated
by its multiple cofactors structurally characterized by their Cdc48/p97-
interacting domains. The UBX or UBX-like containing proteins form the
largest family of Cdc48/p97 cofactors conserved from yeast tomammals. Although the precise function of some members of this
family is currently unclear, the high conservation of the interaction
surface allows all UBX proteins to bind the N-terminal domain of
Cdc48/p97 [8–11] (Fig. 1). Other N domain binding cofactors that
contain interaction motifs corresponding to short stretches of con-
served amino-acids such as the BS1/SHP Box, the VIM (VCP-interaction
motif) or the VBM (VCP-binding motif) were found so far in a limited
number of cellular proteins. In contrast, proteins containing a PUB
domain bind the 10 C-terminal residues of p97 [12–14] (Fig. 1).
Interestingly, phosphorylation of tyrosine 805 by the c-src kinase
prevents this interaction indicating that signaling pathway can
modulate the recruitment of speciﬁc adaptors to Cdc48/p97 [13–15].
Cdc48/p97 cofactors can also be functionally classiﬁed into two
families, substrate-recruiting factors and substrate-processing factors
[16,17]. Theﬁrst class of cofactors corresponds to adaptor proteins able
to interactwith bothCdc48/p97 andubiquitinmoiety onubiquitinated
substrates via dedicated domains. For example, Shp1 (mammalian
p47), the major cofactor involved in the membrane fusion activity of
Cdc48/p97 presents a combination of UBX, BS1/SHP Box and UBA
domains [18]. Some of these adaptors also allow the targeting of
Cdc48/p97 to speciﬁc cellular locations. In yeast, Ubx2, an integral ER
protein recruits Cdc48/p97 and its major cofactors Npl4 and Ufd1 to
the ER, stabilizes the interaction between Cdc48/p97, ERAD substrates
and ubiquitin ligases and thus increases the efﬁciency of the ERAD
pathway [19,20]. Processing factors associated with Cdc48/p97 act
downstream of recruiting factors and mainly inﬂuence the fate of
Cdc48/p97 substrates. They belong to two major families of enzymes,
E3/E4 ubiquitin ligases such as the Ubiquitin chain elongating enzyme
Ufd2 (UFD-2 in Caenorhabditis elegans, [21–23] and deubiquitylation
enzymes (DUB) such as Ataxin3, VCIP135 or Ubp3 involved in ERAD
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Fig. 1. Schematic molecular organization of Cdc48/p97. The binding domains of the different co-factors of Cdc48/p97 mentioned in Table 1 are indicated on the schematic
representation of Cdc48/97.
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[27]. Interaction of Cdc48/p97 with these opposing enzymatic
activities led to the hypothesis of a “decision platform” role for
Cdc48/p97 in the regulation of substrate ubiquitylation [28,29]. A
concerted action of these enzymes has been proposed in either a
“chain editing” model where a DUB can selectively cleave off certain
types of ubiquitin chains from Cdc48/p97 substrates and thus control
their fate, or a “proofreading“ model where a DUB can control theTable 1
Cofactors of Cdc48/p97.
Protein Organisms F
Substrate-recruiting cofactors
Ufd1-Npl4 heterodimer Yeast, metazoans E
Shp1/p47 Yeast, metazoans E
a
p37 Mammalian M
Ubx2 Yeast, metazoans E
Ubx3 Yeast U
Ubx4 Yeast E
Ubx5 Yeast U
Ubx6 Yeast U
Ubx7 Yeast U
Derlin-1 Mammalian E
VIMP Mammalian E
Ubxd1 Mammalian E
Ubxd2 (Erasin) Mammalian E
Ubxd3 Mammalian U
Ubxd4 Mammalian U
Ubxd5 (Socius) Mammalian R
Ubxd6 (Rep-8) Mammalian U
Ubxd7 Mammalian D
Ubxd8 (ETEA) Mammalian U
Ubxd9 (ASPL) Mammalian G
FAF1 Mammalian P
SAKS1 Mammalian P
Substrate-processing cofactors
Ufd2 Yeast, metazoans E
Ufd3 Yeast, metazoans I
gp78 Mammalian E
Hrd1 Mammalian E
Out1 Yeast D
Ubp3-Bre5 Yeast D
VCIP135 Mammalian D
Ataxin-3 Mammalian D
PNGase Mammalian D
HDAC6 Mammalian D
SVIP Mammalian Nlength of ubiquitin chain conjugated to a Cdc48/p97 substrate
(reviewed in ref. [30]).
Concomitantly to the characterization of an increasing number of
Cdc48/p97 cofactors, a growing number of cellular functions appear to
be controlled by Cdc48/p97. In particular, while the Proteasome
System and autophagy have long been viewed as complementary
degradation systems with no point of intersection, studies performed
over the past 3 years clearly demonstrate that ubiquitin conjugationunctions References
RAD, OLE pathway, mitosis, protein degradation [4,5,89–91]
R membrane fusion, Golgi assembly,
utophagosome biogenesis, protein degradation
[11,46,92]
embrane fusion [93]
RAD, protein degradation [11,20]
nknown [11]
RAD, UV-dependent turnover of RNA Pol II [11,94,95]
V-dependent turnover of RNA Pol II [11,95]
nknown [11]
nknown [11]
RAD [96–99]
RAD [99]
RAD [8,12,100]
RAD [8,101]
nknown [8]
nknown [8]
eorganization of the actin cytoskeleton [8,102]
nknown [8]
egradation of HIF1α [8]
nknown [8]
lucose uptake [8,103]
rotein degradation, Apoptosis [8,104]
rotein degradation [8,105,106]
4 polyubiquitylation enzyme [21,28,107]
nhibitor of Ufd2, [27,28]
3 ubiquitin ligase [108]
3 ubiquitin ligase [97,109]
eubiquinating enzyme [28]
eubiquinating complex [27,110]
eubiquinating enzyme [26]
eubiquinating enzyme [24]
eglycosylase [12]
eacetylase (direct interaction with Cdc48/p97?) [111]
egative regulator of ERAD [112]
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some ubiquitin-binding proteins such as Cdc48/p97 appear to play a
major role in this interplay. This review will focus on the recently
described functions of Cdc48/p97 and its cofactors in non-selective
and selective autophagy.
2. Role of Cdc48/p97 in autophagosome formation
Autophagy is an evolutionarily conserved process in eukaryotes
that eliminates longer-lived proteins, macromolecular assemblies as
well as superﬂuous or damaged organelles. Autophagy is generally
induced tomaintain cell survival as a cellular response to various stress
conditions such as periods of starvation or regression of retired tissues.
There are three major types of autophagy, chaperone-mediated
autophagy (CMA), macroautophagy and microautophagy. CMA has
only been characterized in higher eukaryotes and allows selective
degradation of cytosolic proteins in lysosome [31]. Macroautophagy is
characterized by the de novo formation of a double membrane-bound
compartment, the autophagosome, which engulfs cytoplasmic mate-
rial and ultimately fuses with the vacuole or lysosome to allow the
breakdown of its contents. Microautophagy refers to the direct uptake
of cytosolic components by the vacuole/lysosome, through invagina-
tion of its limitingmembrane (Fig. 2). Microautophagy is active during
starvation, thereby compensating for the membrane ﬂux caused by
macroautophagy, and maintaining vacuolar homeostasis. So far, the
yeast genetics allowed the identiﬁcation of 35 AuTophagGy-related
genes (ATG) referred to ATG1 to ATG 35 [32–35]. A subset of the ATG
genes is involved in the formation of the autophagosome, and the
corresponding gene products are referred to as the ‘core’ autophagy
machinery. The core machinery consists in four functional groups:
(1) Atg9 and its cycling factors (2) the phosphatidylinositol 3-kinase
(PtdIns3K) complex (3) the ubiquitin like protein system (4) the
proteins involved in the breakdown of autophagic bodies and the
release of the degraded products back to the cytosol [33,36,37]. Atg8
(LC3 in mammalian cells) is a ubiquitin-like protein essential for the
expansion of the autophagosome precursor, or phagophore, and theMacroautophagy
Phagophore
Autophagosome
Microautophagy
LAMP-2A
Chaperone
Cytosolic 
protein
Chaperone-Mediated
Autophagy
Vacuole/
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Fig. 2. Schematic presentation of autophagy. There are three major types of autophagy
in eukaryotes. Macroautophagy, microautophagy and chaperone-mediated autophagy
(CMA). Macroautophagy is characterized by formation of a double membrane vesicle
called autophagosome that non-selectively engulf cytoplasmic components and
delivers them to the vacuole/lysosome for degradation. Microautophagy involves
sequestration and degradation of cytoplasmic components by invagination of the
vacuole/lysosome membrane. CMA has only been characterized in higher eukaryotes.
In this process, a chaperone protein binds to a speciﬁc cytosolic protein allowing its
unfolding and translocation into the lysosome directly across the lysosome membrane
via the lysosome-associated membrane protein type 2A, LAMP-2A.autophagosome formation [38]. Coupling of Atg8 to phosphatidyl-
ethanolamine (PE) by an ubiquitin-like conjugation system is required
for Atg8 to mediate membrane fusion. Atg8-PE (LC3 II in mammalian
cells) is initially located on the phagophore membrane. Upon
completion of the autophagosome, Atg8 is released from the outer
membrane by Atg4-mediated PE deconjugation while Atg8-PE on the
inner membrane is delivered into the vacuole/lysosome where it is
degraded [39–42].
The role of Cdc48/p97 in autophagosome maturation has been
ﬁrst identiﬁed in mammalian cells, in the context of the IBMPFD
disease caused by mutations within the N-terminal and D1 domains of
Cdc48/p97 [43]. Cells expressing the IBMPFD associated mutants of
Cdc48/p97 display an increased level of the autophagosome markers,
p62 and LC3 II. SiRNA-mediated knockdown of Cdc48/p97 also leads
to the accumulation of p62, LC3 II and GFP-LC3 puncta. Cells with a
decreased expression of Cdc48/p97 fail to degrade LC3 II upon nutrient-
starvation induced autophagy, indicating that the Cdc48/p97 activity
is required for autophagic protein degradation [44]. More precisely,
Cdc48/p97 is necessary for autophagosome–lysosome fusion and
formation of autolysosome [44,45]. The majority of autophagosomes
accumulated in cells expressing Cdc48/p97 mutant forms contain
ubiquitin, suggesting that Cdc48/p97 may be required for the
autophagic degradation of ubiquitylated substrates [45]. However, the
mechanisms responsible for the Cdc48/p97-mediated autophagosome/
lysosome fusion are still unclear although the interaction of Cdc48/p97
with the ubiquitin-like domain of some autophagosome-associated
proteins has been speculated [44].
More recently Cdc48/p97 and its cofactor Shp1 have been
identiﬁed as novel components of autophagosome biogenesis in
yeast [46]. In Saccharomyces cerevisiae, starvation-induced macro-
autophagy monitored by vacuolar degradation of GFP-Atg8 was
indeed blocked in both a cdc48 thermosensitive strain at restrictive
temperature and in shp1Δ cells. In addition, no accumulation of
autophagic bodies could be observed in shp1Δ cells indicating that
autophagosome biogenesis was affected. This effect of Cdc48/p97 and
Shp1 onmacroautophagy ismediated by the direct interaction of Shp1
with Atg8, preferentially in its PE-conjugated form. However this
binding does not involved the ubiquitin-like domain of Atg8 nor the
UBA domain of Shp1. More generally, the function of Cdc48/p97 and
Shp1 in autophagosome biogenesis appeared independent of the
function of these proteins in ubiquitin–proteasome system and the
requirement of the segregase activity of the Cdc48/p97 complex to
extract Atg8-PE prior delipidation has been speculated [46]. Although
Cdc48/p97 has been involved in the fusion of the autophagosomewith
the lysosome inmammalian cells, it seems to be implicated in an early
step of autophagosome formation in yeast. Whether it corresponds to
two distinct functions of Cdc48/p97 mediated by distinct cofactors or
to an evolutionary difference remains to be deﬁned.
3. Cdc48/p97 regulates the selective autophagy
Although macroautophagy is generally considered as a non-
selective or bulk autophagy, several forms of selective autophagy in
which the target is speciﬁc have been reported both in yeast and
higher eukaryotes [47]. That includes yeast speciﬁc cytoplasm-to-
vacuole targeting (CVT) pathway, required for the transport of two
vacuolar enzymes, aminopeptidase I (Ape1) and α-mannosidase
(Ams1) [48,49]. Mitochondria and peroxisomes are degraded via
processes known as mitophagy [50–53] and pexophagy [54,55].
Activation of the unfolded protein response in yeast induces a branch
ofmacroautophagy that selectively targets the endoplasmic reticulum,
so-called ER-phagy[56]. Non-essential portions of the nucleus are
degraded by ‘piecemeal microautophagy of the nucleus’ (PMN) at
nucleus–vacuole junctions [57]. Finally, a selective autophagic path-
way for 60S ribosomal subunit degradation called ribophagy was
recently described [27,58] (Fig. 3).
Reticulophagy
CVT
Cdc48/p97
Vacuole/Lysosome
Pexophagy
Ribophagy
Mitophagy
PMN
Nucleus
Cdc48/p97
Cdc48/p97
Fig. 3. Schematic presentation of selective autophagy. There are several forms of
selective autophagy, including yeast speciﬁc cytoplasm-to-vacuole targeting (CVT)
pathway, required for the transport of two vacuolar enzymes, aminopeptidase I (Ape1)
and α-mannosidase (Ams1), mitophagy and pexophagy involved in the degradation of
mitochondria and peroxisomes, ER-phagy selectively targets the endoplasmic reticu-
lum, ‘piecemeal microautophagy of the nucleus’ (PMN) required for degradation of
non-essential portions of the nucleus at nucleus–vacuole junctions and ribophagy, a
selective autophagic pathway for 60S ribosomal subunit degradation. So far, the role of
Cdc48/p97 has been shown in ribophagy, mitophagy and PMN.
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Under nitrogen starvation, mature ribosomes are degraded in yeast
by ribophagy, that allows a degradation of the 60S ribosomal subunits
faster than degradation of cytoplasmic components by non-selective
autophagy. Ribophagy is monitored in vivo using Rpl25 and Rpl5
ribosomal proteins as markers. Starvation induces degradation of GFP-
tagged Rpl25 or Rpl5 and accumulation of the GFP signal in the vacuole
[58]. To characterize the factors responsible for such a process, a
collection of mutants was screened for defects in vacuolar accumulation
of Rpl25-GFP upon starvation. This approach led to the identiﬁcation of
the deubiquitylating complex Ubp3-Bre5 as a critical ribophagy
component that, interestingly, requires the catalytic activity of this
complex. Recently, Ubp3-Bre5 has been shown to form a tripartite
complexwith Cdc48/p97 and its cofactor Ufd3, a non-essential ubiquitinU
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Fig. 4.Model for the role of Cdc48/p97 and its cofactors in ribophagy. Upon starvation, ubiqu
other ligase(s) may provide a signal for ribophagy. The Ubp3-Bre5-Ufd3-Cdc48/p97 com
sequestration of ribosome in the autophagic membranes (A) or completion of autophagosobinding protein containing a PUL domain [27,59,60]. Ufd3 competes
with the E4 ubiquitin ligase for interaction with Cdc48/p97 and
consequently is believed to limit the rate of polyubiquitylation of
bound substrates [28]. Cdc48/p97 not only regulates the fate of some
Ubp3-Bre5 speciﬁc substrates, but is also required for the Ubp3-Bre5
dependent ribophagy [27,61]. Indeed, the starvation-induced vacuolar
degradation of Rpl25-GFP is inhibited in both a thermosensitive mutant
of cdc48 as well as in ufd3Δ cells. Similarly to Ubp3-Bre5, Cdc48/p97 and
Ufd3 do not participate to degradation of 40S ribosomal subunits.
Although Cdc48/p97, Ufd3 and Ubp3-Bre5 are essential components of
ubiquitin–proteasome system, theproteolytic activity of the proteasome
is not involved in the ribophagy pathway. It has thus been proposed that
efﬁcient ribophagy requires Ubp3-Bre5-Ufd3-Cdc48/p97 dependent
deubiquitylation of speciﬁc target(s) prior to vacuolar degradation
[27]. In agreement with such a hypothesis, the Rsp5 ubiquitin ligase
displays a synthetic ribophagy defect with loss of Ubp3 [62] (Fig. 4).
Whether targets ofUbp3-Bre5-Ufd3-Cdc48belong to the ribosome itself,
to the ribophagy machinery or both, whether deubiquitylation only or
dynamic ubiquitylation/deubiquitylation cycles are required for
efﬁcient ribophagy still remain open questions.
3.2. Cdc48/p97 and mitophagy
Mitophagy is required for the turnover of mitochondria as well as
elimination of damaged or dysfunctional mitochondria. Mitophagy is
also implicated in developmental processes as it allows the removal of
undamaged mitochondria during maturation of reticulocytes and
adapts the amount of mitochondria to the cell energy requirements
[63–65]. Studies in yeast allowed to identify several mitochondrial
proteins required for mitophagy including Atg32, the mitochondrial
receptor, Atg11, the adaptor that mediates recruitment of mitochondria
to the phagophore assembly site and Atg33, Uth1 or Aup1, probable
sensors for age or redox stress [66–71]. In mammalian cells, the
mitochondrial dysfunction is associated with a group of neurodegen-
erativepathologies, includingParkinson's disease (PD). Loss-of-function
mutations in the PARK2 gene represent the most common cause of the
familial form of PD [72]. The PARK2 gene product, Parkin is a ubiquitin
ligase that contains a ubiquitin like domain and twoRingﬁngerdomains
[73–75]. Although essentially located in the cytosol, Parkin is selectively
recruited to the depolarized/damaged mitochondria and mediates
engulfment of dysfunctional mitochondria by autophagosomes prior
elimination [76]. Localization of Parkin to mitochondria is mediated by
the PINK1 protein, a serine/threonine kinase located in the outerDeubiquitylation
Bre5
Cdc48
Ubp3
Ufd3
U
? B
itylation of ribosome or ribosome associated protein(s) by Rsp5 and yet to be identiﬁed
plex may be required for deubiquitylation this (these) substrate(s) to allow either
me formation (B).
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associatedwith familial form of PD [77–80]. In functional mitochondria,
PINK1 located in themitochondrialmembrane is proteolytically cleaved
into a cytosolic fragment that can be degraded by the proteasome
[77,81,82]. The PINK1 cleavage depends on the mitochondrial voltage
and is thus inhibited by loss of membrane potential leading to
accumulation of PINK1 on the impaired mitochondria and recruitment
of Parkin [80]. Parkin thenpromotes the ubiquitylation andproteasomal
degradation of mitofusins, large GTPases anchored in the membrane
and responsible for mitochondrial fusion [83]. Damage-induced loss of
mitofusins prevents fusion of dysfunctional to unaffectedmitochondria,
and targets them to the autophagy pathway. Interestingly, overexpres-
sion of a dominant-negative form of Cdc48/p97 prevents Parkin-
mediated mitofusins degradation as well as elimination of depolarized
mitochondria, indicating that Cdc48/p97 is required formitophagy [84].
However a general defect of the Ubiquitin/Proteasome degradation
system in this experimental condition rather than a speciﬁc involve-
ment of Cdc48/p97 cannot be formally excluded. Whether Cdc48/p97
and Parkin directly interacts to promote ubiquitin-degradation of
mitofusins remains unclear. By analogy to its function in ERAD,
Cdc48/p97 has been proposed, together with cofactors, to extrude
mitofusins and other ubiquitylated proteins from the damaged
mitochondrial membrane and target them for degradation by the
proteasome [84–86].
3.3. Cdc48/p97 and other types of selective autophagy pathways
Besides the role of Cdc48/p97 in the ribophagy and the mitophagy
processes, Cdc48/p97 has also been reported to favor PMN. Indeed the
vacuolar degradation of GFP-Osh1, a micronucleophagic marker is not
only inhibited in a thermosensitive mutant of cdc48/p97 but also in
shp1Δ cells, suggesting that Cdc48/p97 together with its cofactor Shp1
are required for PMN [46]. A role of Cdc48/p97 has been proposed in
the formation of perinuclear aggresomes and in the autophagic
clearance of protein aggregates, a function likely mediated by its
cofactor HDAC6 [87,88]. In contrast Cdc48/p97 does not participate to
the CVT pathway [46]. A complete overview of the Cdc48-dependent
autophagic processes including pexophagy or ER-phagy still remains
to be determined in order to precise the involvement of this chaperone
in each step of this catabolic function.
4. Concluding remarks
Molecular mechanisms responsible for the different autophagic
pathways are far from being fully characterized and understood.
However, as illustrated in this review, Cdc48/p97 already appears as a
major actor involved in distinct general or selective autophagic
processes. Inmost cases so far, Cdc48/p97 acts as a ubiquitin-dependent
chaperone, as it does for classical cellular functions, and already
represents a key factor in the crosstalk between autophagy and
ubiquitin/proteasome catabolic pathways. Interestingly, a segregase
activity of Cdc48/p97 to extract the PE-linked ubiquitin-like Atg8 from
membranes has been speculated [46], suggesting that Cdc48/p97 may
contributemore generally to ubiquitin-like-mediated functions and thus
opening new avenues in the knowledge of this intriguing chaperone.
Acknowledgments
We are grateful to A. Babour and A. Buchberger for critical reading
of the manuscript. This work was supported by the Association for
Research against Cancer.
References
[1] V.E. Pye, I. Dreveny, L.C. Briggs, C. Sands, F. Beuron, X. Zhang, P.S. Freemont, Going
through the motions: the ATPase cycle of p97, J. Struct. Biol. 156 (2006) 12–28.[2] Y. Ye, Diverse functions with a common regulator: ubiquitin takes command of
an AAA ATPase, J. Struct. Biol. 156 (2006) 29–40.
[3] S. Braun, K. Matuschewski, M. Rape, S. Thoms, S. Jentsch, Role of the ubiquitin-
selective CDC48(UFD1/NPL4)chaperone (segregase) in ERAD of OLE1 and other
substrates, EMBO J. 21 (2002) 615–621.
[4] M. Rape, T. Hoppe, I. Gorr, M. Kalocay, H. Richly, S. Jentsch, Mobilization of pro-
cessed, membrane-tethered SPT23 transcription factor by CDC48(UFD1/NPL4),
a ubiquitin-selective chaperone, Cell 107 (2001) 667–677.
[5] K. Ramadan, R. Bruderer, F.M. Spiga, O. Popp, T. Baur, M. Gotta, H.H. Meyer,
Cdc48/p97 promotes reformation of the nucleus by extracting the kinase Aurora
B from chromatin, Nature 450 (2007) 1258–1262.
[6] B. Meusser, C. Hirsch, E. Jarosch, T. Sommer, ERAD: the long road to destruction,
Nat. Cell Biol. 7 (2005) 766–772.
[7] S. Raasi, D.H. Wolf, Ubiquitin receptors and ERAD: a network of pathways to the
proteasome, Semin. Cell Dev. Biol. 18 (2007) 780–791.
[8] G. Alexandru, J. Graumann, G.T. Smith, N.J. Kolawa, R. Fang, R.J. Deshaies, UBXD7
binds multiple ubiquitin ligases and implicates p97 in HIF1alpha turnover, Cell
134 (2008) 804–816.
[9] A. Decottignies, A. Evain, M. Ghislain, Binding of Cdc48p to a ubiquitin-related
UBX domain from novel yeast proteins involved in intracellular proteolysis and
sporulation, Yeast 21 (2004) 127–139.
[10] R. Hartmann-Petersen, M. Wallace, K. Hofmann, G. Koch, A.H. Johnsen, K.B.
Hendil, C. Gordon, The Ubx2 and Ubx3 cofactors direct Cdc48 activity to
proteolytic and nonproteolytic ubiquitin-dependent processes, Curr. Biol. 14
(2004) 824–828.
[11] C. Schuberth, H. Richly, S. Rumpf, A. Buchberger, Shp1 and Ubx2 are adaptors of
Cdc48 involved in ubiquitin-dependent protein degradation, EMBO Rep. 5
(2004) 818–824.
[12] M.D. Allen, A. Buchberger, M. Bycroft, The PUB domain functions as a p97 binding
module in human peptide N-glycanase, J. Biol. Chem. 281 (2006) 25502–25508.
[13] G. Zhao, X. Zhou, L. Wang, G. Li, H. Schindelin, W.J. Lennarz, Studies on peptide:
N-glycanase-p97 interaction suggest that p97 phosphorylation modulates
endoplasmic reticulum-associated degradation, Proc. Natl. Acad. Sci. U.S.A. 104
(2007) 8785–8790.
[14] L. Madsen, K.M. Andersen, S. Prag, T. Moos, C.A. Semple, M. Seeger, R. Hartmann-
Petersen, Ubxd1 is a novel co-factor of the human p97 ATPase, Int. J. Biochem.
Cell Biol. 40 (2008) 2927–2942.
[15] G. Li, G. Zhao, H. Schindelin, W.J. Lennarz, Tyrosine phosphorylation of ATPase
p97 regulates its activity during ERAD, Biochem. Biophys. Res. Commun. 375
(2008) 247–251.
[16] C. Schuberth, A. Buchberger, UBX domain proteins: major regulators of the AAA
ATPase Cdc48/p97, Cell. Mol. Life Sci. 65 (2008) 2360–2371.
[17] L. Madsen, M. Seeger, C.A. Semple, R. Hartmann-Petersen, New ATPase
regulators—p97 goes to the PUB, Int. J. Biochem. Cell Biol. 41 (2009) 2380–2388.
[18] H.H. Meyer, Y. Wang, G. Warren, Direct binding of ubiquitin conjugates by the
mammalian p97 adaptor complexes, p47 and Ufd1-Npl4, EMBO J. 21 (2002)
5645–5652.
[19] O. Neuber, E. Jarosch, C. Volkwein, J. Walter, T. Sommer, Ubx2 links the Cdc48
complex to ER-associated protein degradation, Nat. Cell Biol. 7 (2005) 993–998.
[20] C. Schuberth, A. Buchberger, Membrane-bound Ubx2 recruits Cdc48 to ubiquitin
ligases and their substrates to ensure efﬁcient ER-associated protein degrada-
tion, Nat. Cell Biol. 7 (2005) 999–1006.
[21] H. Richly, M. Rape, S. Braun, S. Rumpf, C. Hoege, S. Jentsch, A series of ubiquitin
binding factors connects CDC48/p97 to substrate multiubiquitylation and
proteasomal targeting, Cell 120 (2005) 73–84.
[22] T. Hoppe, G. Cassata, J.M. Barral, W. Springer, A.H. Hutagalung, H.F. Epstein, R.
Baumeister, Regulation of the myosin-directed chaperone UNC-45 by a novel
E3/E4-multiubiquitylation complex in C. elegans, Cell 118 (2004) 337–349.
[23] P.C. Janiesch, J. Kim, J. Mouysset, R. Barikbin, H. Lochmuller, G. Cassata, S. Krause,
T. Hoppe, The ubiquitin-selective chaperone CDC-48/p97 links myosin assembly
to human myopathy, Nat. Cell Biol. 9 (2007) 379–390.
[24] Q. Wang, L. Li, Y. Ye, Regulation of retrotranslocation by p97-associated
deubiquitinating enzyme ataxin-3, J. Cell Biol. 174 (2006) 963–971.
[25] X. Zhong, R.N. Pittman, Ataxin-3 binds VCP/p97 and regulates retrotranslocation
of ERAD substrates, Hum. Mol. Genet. 15 (2006) 2409–2420.
[26] K. Uchiyama, E. Jokitalo, F. Kano, M. Murata, X. Zhang, B. Canas, R. Newman, C.
Rabouille, D. Pappin, P. Freemont, H. Kondo, VCIP135, a novel essential factor for
p97/p47-mediated membrane fusion, is required for Golgi and ER assembly in
vivo, J. Cell Biol. 159 (2002) 855–866.
[27] B. Ossareh-Nazari, M. Bonizec, M. Cohen, S. Dokudovskaya, F. Delalande, C.
Schaeffer, A. Van Dorsselaer, C. Dargemont, Cdc48 and Ufd3, new partners of the
ubiquitin protease Ubp3, are required for ribophagy, EMBO Rep. 11 (2010)
548–554.
[28] S. Rumpf, S. Jentsch, Functional division of substrate processing cofactors of the
ubiquitin-selective Cdc48 chaperone, Mol. Cell 21 (2006) 261–269.
[29] D. Halawani, M. Latterich, p97: The cell's molecular purgatory? Mol. Cell 22
(2006) 713–717.
[30] A. Buchberger, Control of ubiquitin conjugation by cdc48 and its cofactors,
Subcell. Biochem. 54 (2010) 17–30.
[31] A. Massey, R. Kifﬁn, A.M. Cuervo, Pathophysiology of chaperone-mediated
autophagy, Int. J. Biochem. Cell Biol. 36 (2004) 2420–2434.
[32] D.J. Klionsky, J.M. Cregg,W.A. Dunn Jr., S.D. Emr, Y. Sakai, I.V. Sandoval, A. Sibirny,
S. Subramani, M. Thumm, M. Veenhuis, Y. Ohsumi, A uniﬁed nomenclature for
yeast autophagy-related genes, Dev. Cell 5 (2003) 539–545.
[33] M.A. Lynch-Day, D.J. Klionsky, The Cvt pathway as a model for selective
autophagy, FEBS Lett. 584 (2010) 1359–1366.
143C. Dargemont, B. Ossareh-Nazari / Biochimica et Biophysica Acta 1823 (2012) 138–144[34] K. Suzuki, C. Kondo, M. Morimoto, Y. Ohsumi, Selective transport of alpha-
mannosidase by autophagic pathways: identiﬁcation of a novel receptor,
Atg34p, J. Biol. Chem. 285 (2010) 30019–30025.
[35] V.Y. Nazarko, T.Y. Nazarko, J.C. Farre, O.V. Stasyk, D.Warnecke, S. Ulaszewski, J.M.
Cregg, A.A. Sibirny, S. Subramani, Atg35, a micropexophagy-speciﬁc protein that
regulates micropexophagic apparatus formation in Pichia pastoris, Autophagy 7
(2011).
[36] Z. Xie, D.J. Klionsky, Autophagosome formation: core machinery and adapta-
tions, Nat. Cell Biol. 9 (2007) 1102–1109.
[37] Z. Yang, D.J. Klionsky, Mammalian autophagy: core molecular machinery and
signaling regulation, Curr. Opin. Cell Biol. 22 (2010) 124–131.
[38] Z. Xie, U. Nair, D.J. Klionsky, Atg8 controls phagophore expansion during
autophagosome formation, Mol. Biol. Cell 19 (2008) 3290–3298.
[39] W.P. Huang, S.V. Scott, J. Kim, D.J. Klionsky, The itinerary of a vesicle component,
Aut7p/Cvt5p, terminates in the yeast vacuole via the autophagy/Cvt pathways,
J. Biol. Chem. 275 (2000) 5845–5851.
[40] Y. Kabeya, N. Mizushima, T. Ueno, A. Yamamoto, T. Kirisako, T. Noda, E.
Kominami, Y. Ohsumi, T. Yoshimori, LC3, a mammalian homologue of yeast
Apg8p, is localized in autophagosome membranes after processing, EMBO J. 19
(2000) 5720–5728.
[41] T. Kirisako, M. Baba, N. Ishihara, K. Miyazawa, M. Ohsumi, T. Yoshimori, T. Noda,
Y. Ohsumi, Formation process of autophagosome is traced with Apg8/Aut7p in
yeast, J. Cell Biol. 147 (1999) 435–446.
[42] Y. Ichimura, T. Kirisako, T. Takao, Y. Satomi, Y. Shimonishi, N. Ishihara, N.
Mizushima, I. Tanida, E. Kominami, M. Ohsumi, T. Noda, Y. Ohsumi, A ubiquitin-
like system mediates protein lipidation, Nature 408 (2000) 488–492.
[43] G.D. Watts, J. Wymer, M.J. Kovach, S.G. Mehta, S. Mumm, D. Darvish, A. Pestronk,
M.P. Whyte, V.E. Kimonis, Inclusion body myopathy associated with Paget
disease of bone and frontotemporal dementia is caused by mutant valosin-
containing protein, Nat. Genet. 36 (2004) 377–381.
[44] J.S. Ju, R.A. Fuentealba, S.E. Miller, E. Jackson, D. Piwnica-Worms, R.H. Baloh, C.C.
Weihl, Valosin-containing protein (VCP) is required for autophagy and is
disrupted in VCP disease, J. Cell Biol. 187 (2009) 875–888.
[45] E. Tresse, F.A. Salomons, J. Vesa, L.C. Bott, V. Kimonis, T.P. Yao, N.P. Dantuma, J.P.
Taylor, VCP/p97 is essential for maturation of ubiquitin-containing autophago-
somes and this function is impaired by mutations that cause IBMPFD, Autophagy
6 (2010) 217–227.
[46] R. Krick, S. Bremer, E. Welter, P. Schlotterhose, Y. Muehe, E.L. Eskelinen, M.
Thumm, Cdc48/p97 and Shp1/p47 regulate autophagosome biogenesis in
concert with ubiquitin-like Atg8, J. Cell Biol. 190 (2010) 965–973.
[47] M. Komatsu, Y. Ichimura, Selective autophagy regulates various cellular
functions, Genes Cells 15 (2010) 923–933.
[48] S.V. Scott, M. Baba, Y. Ohsumi, D.J. Klionsky, Aminopeptidase I is targeted to the
vacuole by a nonclassical vesicular mechanism, J. Cell Biol. 138 (1997) 37–44.
[49] M.U.Hutchins, D.J. Klionsky,Vacuolar localizationofoligomeric alpha-mannosidase
requires the cytoplasmtovacuole targeting and autophagypathwaycomponents in
Saccharomyces cerevisiae, J. Biol. Chem. 276 (2001) 20491–20498.
[50] I. Kim, S. Rodriguez-Enriquez, J.J. Lemasters, Selective degradation of mitochon-
dria by mitophagy, Arch. Biochem. Biophys. 462 (2007) 245–253.
[51] T. Kanki, D.J. Klionsky, The molecular mechanism of mitochondria autophagy in
yeast, Mol Microbiol (2010).
[52] I. Bhatia-Kissova, N. Camougrand, Mitophagy in yeast: actors and physiological
roles, FEMS Yeast Res. 10 (2010) 1023–1034.
[53] R.J. Youle, D.P. Narendra, Mechanisms of mitophagy, Nat. Rev. Mol. Cell Biol. 12
(2011) 9–14.
[54] J.A. Kiel, J.A. Komduur, I.J. van der Klei, M. Veenhuis, Macropexophagy in
Hansenula polymorpha: facts and views, FEBS Lett. 549 (2003) 1–6.
[55] Y. Sakai, M. Oku, I.J. van der Klei, J.A. Kiel, Pexophagy: autophagic degradation of
peroxisomes, Biochim. Biophys. Acta 1763 (2006) 1767–1775.
[56] S. Bernales, S. Schuck, P. Walter, ER-phagy: selective autophagy of the
endoplasmic reticulum, Autophagy 3 (2007) 285–287.
[57] E. Kvam, D.S. Goldfarb, Nucleus–vacuole junctions and piecemeal microauto-
phagy of the nucleus in S. cerevisiae, Autophagy 3 (2007) 85–92.
[58] C. Kraft, A. Deplazes, M. Sohrmann, M. Peter, Mature ribosomes are selectively
degraded upon starvation by an autophagy pathway requiring the Ubp3p/Bre5p
ubiquitin protease, Nat. Cell Biol. 10 (2008) 602–610.
[59] M. Ghislain, R.J. Dohmen, F. Levy, A. Varshavsky, Cdc48p interacts with Ufd3p, a
WD repeat protein required for ubiquitin-mediated proteolysis in Saccharomyces
cerevisiae, EMBO J. 15 (1996) 4884–4899.
[60] J.E. Mullally, T. Chernova, K.D. Wilkinson, Doa1 is a Cdc48 adapter that possesses
a novel ubiquitin binding domain, Mol. Cell. Biol. 26 (2006) 822–830.
[61] B. Ossareh-Nazari, M. Cohen, C. Dargemont, The Rsp5 ubiquitin ligase and the
AAA-ATPase Cdc48 control the ubiquitin-mediated degradation of the COPII
component Sec23, Exp. Cell Res. 316 (2010) 3351–3357.
[62] C. Kraft, M. Peter, Is the Rsp5 ubiquitin ligase involved in the regulation of
ribophagy? Autophagy 4 (2008) 838–840.
[63] R.L. Schweers, J. Zhang, M.S. Randall, M.R. Loyd, W. Li, F.C. Dorsey, M. Kundu, J.T.
Opferman, J.L. Cleveland, J.L. Miller, P.A. Ney, NIX is required for programmed
mitochondrial clearance during reticulocyte maturation, Proc. Natl. Acad. Sci.
U.S.A. 104 (2007) 19500–19505.
[64] M. Mortensen, D.J. Ferguson, M. Edelmann, B. Kessler, K.J. Morten, M. Komatsu,
A.K. Simon, Loss of autophagy in erythroid cells leads to defective removal of
mitochondria and severe anemia in vivo, Proc. Natl. Acad. Sci. U.S.A. 107
(2010) 832–837.
[65] T. Kanki, D.J. Klionsky, Mitophagy in yeast occurs through a selectivemechanism,
J. Biol. Chem. 283 (2008) 32386–32393.[66] T. Kanki, D.J. Klionsky, Atg32 is a tag for mitochondria degradation in yeast,
Autophagy 5 (2009) 1201–1202.
[67] T. Kanki, K. Wang, M. Baba, C.R. Bartholomew, M.A. Lynch-Day, Z. Du, J. Geng, K.
Mao, Z. Yang, W.L. Yen, D.J. Klionsky, A genomic screen for yeast mutants
defective in selective mitochondria autophagy, Mol. Biol. Cell 20 (2009)
4730–4738.
[68] K. Okamoto, N. Kondo-Okamoto, Y. Ohsumi, Mitochondria-anchored receptor
Atg32 mediates degradation of mitochondria via selective autophagy, Dev. Cell
17 (2009) 87–97.
[69] K. Okamoto, N. Kondo-Okamoto, Y. Ohsumi, A landmark protein essential for
mitophagy: Atg32 recruits the autophagic machinery to mitochondria, Autop-
hagy 5 (2009) 1203–1205.
[70] I. Kissova, M. Defﬁeu, S. Manon, N. Camougrand, Uth1p is involved in the
autophagic degradation ofmitochondria, J. Biol. Chem. 279 (2004) 39068–39074.
[71] R. Tal, G. Winter, N. Ecker, D.J. Klionsky, H. Abeliovich, Aup1p, a yeast
mitochondrial protein phosphatase homolog, is required for efﬁcient stationary
phase mitophagy and cell survival, J. Biol. Chem. 282 (2007) 5617–5624.
[72] T. Kitada, S. Asakawa, N. Hattori, H. Matsumine, Y. Yamamura, S. Minoshima, M.
Yokochi, Y. Mizuno, N. Shimizu, Mutations in the parkin gene cause autosomal
recessive juvenile parkinsonism, Nature 392 (1998) 605–608.
[73] Y. Imai, M. Soda, R. Takahashi, Parkin suppresses unfolded protein stress-
induced cell death through its E3 ubiquitin-protein ligase activity, J. Biol. Chem.
275 (2000) 35661–35664.
[74] H. Shimura, N. Hattori, S. Kubo, Y. Mizuno, S. Asakawa, S. Minoshima, N. Shimizu,
K. Iwai, T. Chiba, K. Tanaka, T. Suzuki, Familial Parkinson disease gene product,
parkin, is a ubiquitin-protein ligase, Nat. Genet. 25 (2000) 302–305.
[75] Y. Zhang, J. Gao, K.K. Chung, H. Huang, V.L. Dawson, T.M. Dawson, Parkin
functions as an E2-dependent ubiquitin-protein ligase and promotes the
degradation of the synaptic vesicle-associated protein, CDCrel-1, Proc. Natl.
Acad. Sci. U.S.A. 97 (2000) 13354–13359.
[76] D. Narendra, A. Tanaka, D.F. Suen, R.J. Youle, Parkin is recruited selectively to
impaired mitochondria and promotes their autophagy, J. Cell Biol. 183 (2008)
795–803.
[77] C. Zhou, Y. Huang, Y. Shao, J. May, D. Prou, C. Perier, W. Dauer, E.A. Schon, S.
Przedborski, The kinase domain of mitochondrial PINK1 faces the cytoplasm,
Proc. Natl. Acad. Sci. U.S.A. 105 (2008) 12022–12027.
[78] N. Matsuda, S. Sato, K. Shiba, K. Okatsu, K. Saisho, C.A. Gautier, Y.S. Sou, S. Saiki, S.
Kawajiri, F. Sato, M. Kimura, M. Komatsu, N. Hattori, K. Tanaka, PINK1 stabilized
by mitochondrial depolarization recruits Parkin to damaged mitochondria and
activates latent Parkin for mitophagy, J. Cell Biol. 189 (2010) 211–221.
[79] C. Vives-Bauza, C. Zhou, Y. Huang, M. Cui, R.L. de Vries, J. Kim, J. May, M.A.
Tocilescu, W. Liu, H.S. Ko, J. Magrane, D.J. Moore, V.L. Dawson, R. Grailhe, T.M.
Dawson, C. Li, K. Tieu, S. Przedborski, PINK1-dependent recruitment of Parkin to
mitochondria in mitophagy, Proc. Natl. Acad. Sci. U.S.A. 107:378-383.
[80] D.P. Narendra, S.M. Jin, A. Tanaka, D.F. Suen, C.A. Gautier, J. Shen, M.R. Cookson,
R.J. Youle, PINK1 is selectively stabilized on impaired mitochondria to activate
Parkin, PLoS Biol. 8 (2010) e1000298.
[81] A. Beilina, M. Van Der Brug, R. Ahmad, S. Kesavapany, D.W. Miller, G.A. Petsko,
M.R. Cookson, Mutations in PTEN-induced putative kinase 1 associated with
recessive parkinsonism have differential effects on protein stability, Proc. Natl.
Acad. Sci. U.S.A. 102 (2005) 5703–5708.
[82] W. Lin, U.J. Kang, Characterization of PINK1 processing, stability, and subcellular
localization, J. Neurochem. 106 (2008) 464–474.
[83] A. Zorzano, M. Liesa, D. Sebastian, J. Segales, M. Palacin, Mitochondrial fusion
proteins: dual regulators of morphology and metabolism, Semin. Cell Dev. Biol.
21 (2010) 566–574.
[84] A. Tanaka, M.M. Cleland, S. Xu, D.P. Narendra, D.F. Suen, M. Karbowski, R.J. Youle,
Proteasome and p97 mediate mitophagy and degradation of mitofusins induced
by Parkin, J. Cell Biol. 191 (2010) 1367–1380.
[85] J.M. Heo, N. Livnat-Levanon, E.B. Taylor, K.T. Jones, N. Dephoure, J. Ring, J. Xie, J.L.
Brodsky, F. Madeo, S.P. Gygi, K. Ashraﬁ, M.H. Glickman, J. Rutter, A stress-
responsive system for mitochondrial protein degradation, Mol. Cell 40 (2010)
465–480.
[86] S. Xu, G. Peng, Y. Wang, S. Fang, M. Karbowski, The AAA-ATPase p97 is essential
for outer mitochondrial membrane protein turnover, Mol. Biol. Cell 22 (2011)
291–300.
[87] J.S. Ju, S.E. Miller, P.I. Hanson, C.C. Weihl, Impaired protein aggregate handling
and clearance underlie the pathogenesis of p97/VCP-associated disease, J. Biol.
Chem. 283 (2008) 30289–30299.
[88] J.S. Ju, C.C. Weihl, Inclusion body myopathy, Paget's disease of the bone and
fronto-temporal dementia: a disorder of autophagy, Hum. Mol. Genet. 19 (2010)
R38–45.
[89] S. Jentsch, S. Rumpf, Cdc48 (p97): a "molecular gearbox" in the ubiquitin
pathway? Trends Biochem. Sci. 32 (2007) 6–11.
[90] N.W. Bays, S.K. Wilhovsky, A. Goradia, K. Hodgkiss-Harlow, R.Y. Hampton,
HRD4/NPL4 is required for the proteasomal processing of ubiquitinated ER
proteins, Mol. Biol. Cell 12 (2001) 4114–4128.
[91] Y. Ye, H.H. Meyer, T.A. Rapoport, The AAA ATPase Cdc48/p97 and its partners
transport proteins from the ER into the cytosol, Nature 414 (2001) 652–656.
[92] H. Kondo, C. Rabouille, R. Newman, T.P. Levine, D. Pappin, P. Freemont, G.
Warren, p47 is a cofactor for p97-mediated membrane fusion, Nature 388
(1997) 75–78.
[93] K. Uchiyama, G. Totsukawa, M. Puhka, Y. Kaneko, E. Jokitalo, I. Dreveny, F.
Beuron, X. Zhang, P. Freemont, H. Kondo, p37 is a p97 adaptor required for Golgi
and ER biogenesis in interphase and at the end of mitosis, Dev. Cell 11 (2006)
803–816.
144 C. Dargemont, B. Ossareh-Nazari / Biochimica et Biophysica Acta 1823 (2012) 138–144[94] S.M. Alberts, C. Sonntag, A. Schafer, D.H. Wolf, Ubx4 modulates cdc48 activity
and inﬂuences degradation of misfolded proteins of the endoplasmic reticulum,
J. Biol. Chem. 284 (2009) 16082–16089.
[95] R. Verma, R. Oania, R. Fang, G.T. Smith, R.J. Deshaies, Cdc48/p97 mediates UV-
dependent turnover of RNA Pol II, Mol. Cell 41 (2011) 82–92.
[96] A. Schulze, S. Standera, E. Buerger, M. Kikkert, S. van Voorden, E. Wiertz, F.
Koning, P.M. Kloetzel, M. Seeger, The ubiquitin-domain protein HERP forms a
complex with components of the endoplasmic reticulum associated degradation
pathway, J. Mol. Biol. 354 (2005) 1021–1027.
[97] Y. Ye, Y. Shibata, M. Kikkert, S. van Voorden, E.Wiertz, T.A. Rapoport, Recruitment
of the p97 ATPase and ubiquitin ligases to the site of retrotranslocation at the
endoplasmic reticulum membrane, Proc. Natl. Acad. Sci. U.S.A. 102 (2005)
14132–14138.
[98] B.N. Lilley, H.L. Ploegh, Amembrane protein required for dislocation of misfolded
proteins from the ER, Nature 429 (2004) 834–840.
[99] Y. Ye, Y. Shibata, C. Yun, D. Ron, T.A. Rapoport, A membrane protein complex
mediates retro-translocation from the ER lumen into the cytosol, Nature 429
(2004) 841–847.
[100] M. Nagahama, M. Ohnishi, Y. Kawate, T. Matsui, H. Miyake, K. Yuasa, K. Tani, M.
Tagaya, A. Tsuji, UBXD1 is a VCP-interacting protein that is involved in ER-
associated degradation, Biochem. Biophys. Res. Commun. 382 (2009) 303–308.
[101] J. Liang, C. Yin, H. Doong, S. Fang, C. Peterhoff, R.A. Nixon, M.J. Monteiro,
Characterization of erasin (UBXD2): a new ER protein that promotes ER-
associated protein degradation, J. Cell Sci. 119 (2006) 4011–4024.
[102] H. Katoh, A. Harada, K. Mori, M. Negishi, Socius is a novel Rnd GTPase-interacting
protein involved in disassembly of actin stress ﬁbers, Mol. Cell. Biol. 22 (2002)
2952–2964.
[103] J.S. Bogan, N. Hendon, A.E. McKee, T.S. Tsao, H.F. Lodish, Functional cloning of
TUG as a regulator of GLUT4 glucose transporter trafﬁcking, Nature 425 (2003)
727–733.[104] E.J. Song, S.H. Yim, E. Kim, N.S. Kim, K.J. Lee, Human Fas-associated factor 1,
interacting with ubiquitinated proteins and valosin-containing protein, is
involved in the ubiquitin–proteasome pathway, Mol. Cell. Biol. 25 (2005)
2511–2524.
[105] H. McNeill, A. Knebel, J.S. Arthur, A. Cuenda, P. Cohen, A novel UBA and UBX
domain protein that binds polyubiquitin and VCP and is a substrate for SAPKs,
Biochem. J. 384 (2004) 391–400.
[106] D.P. LaLonde, A. Bretscher, The UBX protein SAKS1 negatively regulates
endoplasmic reticulum-associated degradation and p97-dependent degrada-
tion, J. Biol. Chem. 286 (2011) 4892–4901.
[107] M. Koegl, T. Hoppe, S. Schlenker, H.D. Ulrich, T.U. Mayer, S. Jentsch, A novel
ubiquitination factor, E4, is involved in multiubiquitin chain assembly, Cell 96
(1999) 635–644.
[108] X. Zhong, Y. Shen, P. Ballar, A. Apostolou, R. Agami, S. Fang, AAA ATPase
p97/valosin-containing protein interacts with gp78, a ubiquitin ligase for
endoplasmic reticulum-associated degradation, J. Biol. Chem. 279 (2004)
45676–45684.
[109] G. Morreale, L. Conforti, J. Coadwell, A.L. Wilbrey, M.P. Coleman, Evolutionary
divergence of valosin-containing protein/cell division cycle protein 48 binding
interactions among endoplasmic reticulum-associated degradation proteins,
FEBS J. 276 (2009) 1208–1220.
[110] M. Cohen, F. Stutz, N. Belgareh, R. Haguenauer-Tsapis, C. Dargemont, Ubp3
requires a cofactor, Bre5, to speciﬁcally de-ubiquitinate the COPII protein, Sec23,
Nat. Cell Biol. 5 (2003) 661–667.
[111] C. Boyault, B. Gilquin, Y. Zhang, V. Rybin, E. Garman, W. Meyer-Klaucke, P.
Matthias, C.W. Muller, S. Khochbin, HDAC6-p97/VCP controlled polyubiquitin
chain turnover, EMBO J. 25 (2006) 3357–3366.
[112] P. Ballar, Y. Zhong, M. Nagahama, M. Tagaya, Y. Shen, S. Fang, Identiﬁcation of
SVIP as an endogenous inhibitor of endoplasmic reticulum-associated degrada-
tion, J. Biol. Chem. 282 (2007) 33908–33914.
